Skip to main content
. Author manuscript; available in PMC: 2016 Jul 1.
Published in final edited form as: Pediatr Blood Cancer. 2015 Mar 11;62(7):1184–1189. doi: 10.1002/pbc.25475

Figure 1. Deviation from Protocol-Mandated Chemotherapy Exposure by Chemotherapy Agent.

Figure 1

A. Cytarabine Course 1 (356 Total Courses)

B. Cytarabine Course 2 (331 Total Courses)

C. Daunorubicin Course 1 (341 Total Courses)

D. Etoposide Course 1 (347 Total Courses)

Zero doses incorrect indicates a perfect match. Data are shown from Courses 1 and 2 for cytarabine and Course 1 only for daunorubicin and etoposide for patients who received at least 1 dose of chemotherapy.